Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 14/20 | 0.58 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | SHBG | P04278 | 1/20 | 0.55 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.55 |
| ▸ | GUSB | P08236 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | G6PD | P11413 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3797856 | 1.00 | CYP19A1 (0.58) | CYP19A1SRD5A1MEN1LMNASHBG | |
| SCHEMBL10274355 | 0.92 | CYP19A1 (0.66) | CYP19A1MEN1LMNASHBGSERPINA6 | |
| SCHEMBL7523372 | 0.84 | CYP17A1 (0.57) | CYP19A1SRD5A1MEN1LMNASHBG | |
| SCHEMBL7523360 | 0.84 | CYP17A1 (0.57) | CYP19A1SRD5A1MEN1LMNASHBG | |
| SCHEMBL7523365 | 0.84 | CYP17A1 (0.57) | CYP19A1SRD5A1MEN1LMNASHBG | |
| SCHEMBL3803940 | 0.84 | CYP17A1 (0.57) | CYP19A1SRD5A1MEN1LMNASHBG | |
| SCHEMBL3803939 | 0.84 | CYP17A1 (0.57) | CYP19A1SRD5A1MEN1LMNASHBG | |
| SCHEMBL5183889 | 0.84 | SRD5A1 (0.53) | CYP19A1SRD5A1 | |
| SCHEMBL5183886 | 0.84 | SRD5A1 (0.53) | CYP19A1SRD5A1 | |
| SCHEMBL5423822 | 0.83 | SRD5A1 (0.51) | CYP19A1SRD5A1MEN1LMNASHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0880540-B1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | AVENTIS PHARMA INC (US) | 2002-06-12 | — | — | EP | disclosed |
| US-6365597-B1 | FOR THERAPY OF ANDROGEN AND ESTROGEN MEDIATED DISORDERS, INCLUDING BENIGN PROSTATIC HYPERPLASIA, ANDROGEN MEDIATED PROSTATE CANCER, ESTROGEN MEDIATED BREAST CANCER AND ACNE | AVENTIS PHARMACEUTICALS INC. | 2002-04-02 | — | — | US | disclosed |
| EP-0705273-B1 | 17-HALOGENO-4-AZAANDROSTENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | RICHTER GEDEON VEGYESZET (HU) | 2002-03-27 | — | — | EP | disclosed |
| EP-0705272-B1 | NOVEL PROCESS FOR PREPARING 17 BETA-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES | RICHTER GEDEON VEGYESZET (HU) | 2002-03-27 | — | — | EP | disclosed |
| EP-0880540-A1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | HOECHST MARION ROUSSEL, INC. (US) | 1998-12-02 | — | — | EP | disclosed |
| WO-1997030069-A1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | HOECHST MARION ROUSSEL, INC. (US) | 1997-08-21 | — | — | WO | disclosed |
| US-5583228-A | 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1996-12-10 | — | — | US | disclosed |
| US-5583138-A | REDUCTASE INHIBITOR; SKIN DISORDERS | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1996-12-10 | — | — | US | disclosed |
| EP-0705273-A1 | 17-HALOGENO-4-AZAANDROSTENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1996-04-10 | — | — | EP | disclosed |
| EP-0705272-A1 | NOVEL PROCESS FOR PREPARING 17 BETA-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1996-04-10 | — | — | EP | disclosed |
| EP-0662977-A1 | NOVEL 17$g(b)-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1995-07-19 | — | — | EP | disclosed |
| WO-1995000532-A1 | 17-HALOGENO-4-AZAANDROSTENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | Richter Gedeon Vegyészeti Gyár Rt. (HU) | 1995-01-05 | — | — | WO | disclosed |
| WO-1995000531-A1 | NOVEL PROCESS FOR PREPARING 17β-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES | Richter Gedeon Vegyészeti Gyár Rt. (HU) | 1995-01-05 | — | — | WO | disclosed |
| WO-1994007909-A1 | NOVEL 17β-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME | Richter Gedeon Vegyészeti Gyár Rt. (HU) | 1994-04-14 | — | — | WO | disclosed |